Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05290675 · ClinicalTrials.gov registry record
Quantra QPlus Sample Type Comparison
A clinical trial of Coagulation Defect; Bleeding, sponsored by HemoSonics.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05290675 is a study of Coagulation Defect; Bleeding that has completed, run by HemoSonics. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05290675, a study of Coagulation Defect; Bleeding, has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center prospective observational study to compare QPlus parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing cardiac surgery.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantra QPlus System
Study Locations (1)
Ohio
- Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2022-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05290675
The ClinicalTrials.gov registry entry for NCT05290675 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coagulation Defect; Bleeding appearing as the primary indexed condition, and to 1 intervention - of which Quantra QPlus System is the first listed.
NCT05290675 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05290675 about?
NCT05290675 is a clinical study titled "Quantra QPlus Sample Type Comparison". This is a single center prospective observational study to compare QPlus parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing cardiac surgery.
What is the current status of trial NCT05290675?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-11-04. Estimated completion is 2022-11-02.
What conditions does trial NCT05290675 study?
This clinical trial studies the following conditions: Coagulation Defect; Bleeding.
What interventions are being tested in trial NCT05290675?
The interventions under investigation include: Quantra QPlus System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05290675?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05290675 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coagulation Defect; Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.